IMUC ramping, breakout >1.65, added
Under the radar still, been adding to initial position 1.28, @1.43 & 1.55.
Anyone else following? thoughts?
IMUC is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently completed a Phase I trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor associated antigens for glioblastoma. The Company plans to start patient enrollment in a multi center Phase II study in Q1, 2011. The Company's “off the shelf” therapeutic vaccine product candidate (ICT-121) targeting cancer stem cells for multiple cancer indications is targeted by IMUC to enter clinical trials during the first half of 2011.
